Feasibility and Diagnostic Validity of Cardiac Magnetic Resonance Imaging in Octogenarians and Nonagenarians: A Retrospective Single-Center Analysis of 1153 Consecutive Patients
This retrospective study of 1,153 patients aged 80 and older demonstrates that cardiac magnetic resonance imaging is highly feasible and diagnostically valid in the elderly, with older age independently predicting premature scan termination and specific clinical indications (such as myocarditis and viability assessment) rather than patient demographics driving limited evaluability.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the human heart as a complex, rhythmic engine that keeps the body running. For decades, doctors have had a few different ways to peek inside this engine to see if it's healthy, but many of those methods involve X-rays (which use radiation) or require the patient to hold their breath for a long time while lying very still. Enter Cardiac Magnetic Resonance Imaging, or CMR. Think of CMR as a super-powered, giant magnet that takes incredibly detailed, 3D movies of the heart without using any radiation. It's like having a high-definition camera that can see the heart's muscle, its blood flow, and even tiny scars, all while the patient lies in a tube.
However, there's a catch: this "movie" takes a long time to shoot, and the patient has to stay perfectly still inside a narrow, noisy tube. For a young, healthy person, this is usually fine. But for the elderly—people in their 80s and 90s, often called octogenarians and nonagenarians—the challenge is much bigger. They might have trouble holding their breath, feel claustrophobic, have other health issues, or simply be too tired to finish the long scan. Doctors have known that heart disease is common in older people, but they didn't have a clear map of whether this powerful MRI tool actually works for them in the real world. They needed to know: Can we actually get a good picture of an 85-year-old's heart, or do the scans often get cancelled or come out blurry?
This study decided to find out by looking at a massive pile of real-world data. The researchers gathered information on 1,153 consecutive patients who were all 80 years old or older (ranging from 80 up to a remarkable 100 years old) and had undergone a heart MRI at a single hospital in Germany between 2014 and 2021. They wanted to solve two specific mysteries: First, how often do these scans get stopped before they are finished (premature termination)? Second, how often do the scans finish but turn out to be too blurry or unclear to give a diagnosis (limited evaluability)? They also wanted to figure out what factors were the real culprits behind these problems: Was it just getting older, or was it something about why the scan was being done in the first place?
The results were surprisingly reassuring, but with some important nuances. First, the "success rate" was incredibly high. Out of all those 1,153 elderly patients, the scan was stopped early in only 45 cases, which is just 3.9%. That means in more than 96 out of 100 cases, the elderly patients were able to complete the scan. Furthermore, in 94.0% of all examinations (1,084 scans), the doctors got a clear, usable answer to their medical question. This suggests that, contrary to some fears, the vast majority of people in their 80s and 90s can successfully undergo this detailed heart imaging.
However, the study did find a few patterns that act like warning signs. When looking at why a scan might get stopped early, the researchers found that age really did matter. For every single year a patient got older, their odds of stopping the scan early went up by about 13%. So, a 90-year-old was statistically more likely to quit the scan than an 80-year-old, even though both groups are considered "elderly." Interestingly, the reason for the scan didn't seem to matter for stopping early; it was purely about the patient's age and tolerance. The most common reason for stopping was simply that the patient decided they didn't want to continue, rather than a specific medical emergency like chest pain.
The second mystery—why a finished scan might be too blurry to read—had a completely different answer. Here, the patient's age and gender didn't matter at all. A 95-year-old was just as likely to get a clear picture as an 80-year-old. Instead, the "why" of the scan was the boss. The type of test being performed was the biggest predictor of whether the image would be clear.
The researchers discovered that scans looking for heart inflammation (myocarditis) or checking for dead heart muscle after a heart attack (viability) were much riskier. These specific types of scans were five times more likely to end up with limited evaluability compared to standard stress tests. Think of it like trying to take a photo of a moving car: if you are trying to capture a fast, complex action (like inflammation or tissue damage), the camera needs to be perfect, and any tiny shake ruins the picture. Older patients often have trouble holding their breath or keeping their heart rhythm steady, which makes these complex "photos" blurry. On the other hand, scans done to check the veins around the heart before or after a procedure to fix irregular heartbeats (PVI) were remarkably reliable, with very few blurry results.
In short, the paper concludes that Cardiac MRI is a feasible and powerful tool for the very elderly. While getting older does make it slightly harder to finish the scan, the biggest factor in getting a clear, usable image isn't the patient's age—it's the type of test being ordered. If a doctor needs to check for inflammation or old heart damage in an 85-year-old, they need to be extra careful with the planning because those specific tests are harder to get right. But for many other heart checks, the machine works just as well for a 90-year-old as it does for anyone else.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.